Procoralan heart failure licensed - Ivabradine for chronic heart failure? - Drug and
Amgen files Procoralan for Heart Failure Heart Failure in the US. Amgen licensed the product from Servier which markets the drug outside the US for Stable Angina
Aim. To study influence of ivabradine as compared with bisoprolol on clinical and hemodynamic indices, exercise tolerance, endothelial function, quality of life (QL) and erectile function in patients with ischemic heart disease.
Ivabradine, marketed under the trade name Corlanor among others, is a medication used for the symptomatic management of stable heart-related chest pain and heart failure not fully managed by beta blockers.
Atrial fibrillation associated with ivabradine treatment: (Procoralan, Servier) is a heart rate lowering drug which for treatment of chronic heart failure
vabradine 5 and 7. 5mg film-coated tablets (Procoralan) SMC No. (805/12) Servier Laboratories Ltd current to be licensed for the treatment of heart failure.
Procoralan (ivabradine) can now Procoralan: new option for chronic heart failure. Procoralan is also licensed for the treatment of chronic stable angina.